True north to invest inr 150 crore in ACN healthcare to revolutionise healthcare revenue cycle

True North Private Equity via its alternative investment platform, the Credit Opportunities Fund I, has  entered into definitive agreements to invest INR 150 crore in ACN Healthcare RCM, a leading Revenue Cycle  Management (RCM) solutions provider with operations in India and a global client base. 

ACN Healthcare has demonstrated robust growth of over 68% CAGR over the last 3 years. The funds will be  utilised towards growth and expansion of ACN Healthcare’s service portfolio, pursue strategic initiatives, and  establish new delivery facilities, strengthening its ability to serve global healthcare providers. 

Wodehouse Capital Advisors acted as the exclusive financial advisor to ACN Healthcare for the transaction  and continues to advise the company on its ongoing fundraise and strategic initiatives. Sources indicate that  several leading private equity funds are also in advanced discussions to participate and invest upto an  additional US$ 20 million in the current funding round. 

Founded by Chaman Baid, a seasoned entrepreneur with over three decades of experience in building  scalable healthcare and IT services businesses, ACN Healthcare delivers customised, end-to-end RCM  solutions to hospitals and physician practices worldwide. The company operates at scale with a workforce of  over 3,000+ trained professionals across 4 state-of-the-art delivery centers. ACN’s offerings span RCM and  healthcare-focused business process outsourcing services, serving large hospitals, specialty practices,  emergency departments, and critical access facilities across the US. With robust infrastructure, seamless  technology integration, and deep healthcare specialization, ACN Healthcare delivers comprehensive RCM  solutions that enhance revenue realization, reduce operational costs, improve the provider’s financial  management and enhance patient experience. As the company scales its platform, ACN is well  positioned to emerge as a global leader in revenue cycle excellence. 

Commenting on the transaction, Chaman Baid, Founder, ACN Healthcare said, “We are delighted to  partner with True North, a well-regarded investment platform with deep experience in partnering with growth oriented businesses. Their deep understanding of healthcare and technology services, combined with a  strong institutional platform, makes them an ideal partner for ACN’s next phase of growth. This partnership  significantly strengthens our ability to deliver innovative, high-impact solutions to our clients globally.” 

Kapil Singhal, Managing Partner, True North-Private Credit added, “We are pleased to partner with  ACN Healthcare in the rapidly expanding healthcare RCM space. Under Chaman’s leadership, ACN has built  a strong reputation for operational excellence and client delivery. We believe the company is well positioned  to capitalise on the next phase of industry growth, and this investment reflects True North’s strategy of backing  high-quality businesses led by exceptional founders.”

The RCM industry that currently employs over approximately 300,000 workforce continues to attract strong  interest from both financial and strategic investors, driven by rising healthcare complexity, regulatory  intensity, labor shortages, and consolidation among providers.  

Demand for RCM services in India is accelerating on the back of rising global healthcare outsourcing, digital  transformation, and complex payer ecosystems, positioning India as a critical delivery hub; the market is  expected to grow at double-digit CAGR (~15–17%) over the next decade, supported by AI-led automation and  sustained international demand. India now hosts over 50% of the global RCM workforce, reflecting the strong  offshore shift from overseas healthcare providers. 

The global RCM market is estimated to exceed USD 300 billion, growing at a strong double-digit CAGR, with  increasing outsourcing and technology adoption. India has emerged as a critical global hub for RCM,  supported by deep talent availability, cost efficiency, healthcare domain expertise, and rapid adoption of AI led automation. Over the next five years, sustained demand from U.S. healthcare providers and scale-driven  consolidation are expected to further accelerate growth.